awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33429608-1575E2D6-0FA4-45EF-B230-F0BA815C8900
Q33429608-1575E2D6-0FA4-45EF-B230-F0BA815C8900
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429608-1575E2D6-0FA4-45EF-B230-F0BA815C8900
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer.
P2860
Q33429608-1575E2D6-0FA4-45EF-B230-F0BA815C8900
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429608-1575E2D6-0FA4-45EF-B230-F0BA815C8900
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8fe5aa4e13c27756d62f34e1998a5fad0e2b19be
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.